TOKYO, Mar 25, 2025 – (JCN Newswire via SeaPRwire.com) – Eisai Co., Ltd. announced today that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI®” (lecanemab) for the treatment of early Alzheimer’s disease (early AD *) has received the Prime Minister’s Awar […]

TOKYO, Mar 26, 2025 – (JCN Newswire via SeaPRwire.com) – TANAKA PRECIOUS METAL GROUP Co., Ltd. (Head office: Chuo-ku, Tokyo: Group CEO: Koichiro Tanaka) announces that its Board of Directors tentatively decided, at a meeting held on February 17, 2025, the appointment of an executive for […]